D051498Chemicals & DrugsD08.811.913.696.620.682.725.400.179D12.776.543.750.060.442D12.776.543.750.750.400.370.875D12.776.624.664.700.792230.995283Receptor, Fibroblast Growth Factor, Type 3Faculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonCancer BiologyWake Forest School of MedicineAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessor27302823Atala AThe Journal of urologyAtala A. Re: Mutations in TERT Promoter and FGFR3 and Telomere Length in Bladder Cancer. J Urol. 2016 04; 195(4 Pt 1):1168-9.J Urol2016-01-21T00:00:002016Re: Mutations in TERT Promoter and FGFR3 and Telomere Length in Bladder Cancer.WeiZhangWei Zhang PhD36.09032400000000-80.266491000000002027Zhang, WeiProfessor28379477Granberg KJ, Annala M, Lehtinen B, Kesseli J, Haapasalo J, Ruusuvuori P, Yli-Harja O, Visakorpi T, Haapasalo H, Nykter M, Zhang WNeuro-oncologyGranberg KJ, Annala M, Lehtinen B, Kesseli J, Haapasalo J, Ruusuvuori P, Yli-Harja O, Visakorpi T, Haapasalo H, Nykter M, Zhang W. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas. Neuro Oncol. 2017 Sep 01; 19(9):1206-1216.Neuro Oncol2017-09-01T00:00:002017Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.20Professor30360346Atala AThe Journal of urologyAtala A. Re: An FGFR3/MYC Positive Feedback Loop Provides New Opportunities for Targeted Therapies in Bladder Cancers. J Urol. 2018 11; 200(5):947-948.J Urol2018-08-07T00:00:002018Re: An FGFR3/MYC Positive Feedback Loop Provides New Opportunities for Targeted Therapies in Bladder Cancers.Urologyhttp://www.wfirm.orgWFIRM35151844Li T, Mehraein-Ghomi F, Forbes ME, Namjoshi SV, Ballard EA, Song Q, Chou PC, Wang X, Parker Kerrigan BC, Lang FF, Lesser G, Debinski W, Yang X, Zhang WMolecular therapy : the journal of the American Society of Gene TherapyLi T, Mehraein-Ghomi F, Forbes ME, Namjoshi SV, Ballard EA, Song Q, Chou PC, Wang X, Parker Kerrigan BC, Lang FF, Lesser G, Debinski W, Yang X, Zhang W. HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion. Mol Ther. 2022 Apr 06; 30(4):1610-1627.Mol Ther2022-02-10T00:00:002022HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion.true1ProfessorProfessortrue1ProfessorProfessor21459758Wang M, Chu H, Yan F, Qin C, Li P, Yuan L, Yin C, Xu J, Zhang ZCarcinogenesisWang M, Chu H, Yan F, Qin C, Li P, Yuan L, Yin C, Xu J, Zhang Z. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis. 2011 Jun; 32(6):872-5.Carcinogenesis2011-03-31T00:00:002011Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.0.634530.3110622research area of0.6375370.1425295subject area for